Altria Group stock holds above $64 as earnings and guidance steady
Published on 08/13/2026 at 17:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Altria Group Inc. (US02209S1033) stock traded in the mid-$60 range on August 13, 2026, with shares opening at $64.43 and sitting below both the 50-day and 200-day moving averages as recent analyst coverage highlighted a cautious but stable outlook for the tobacco major. Per recent market data as of August 13, 2026, the shares were indicated around $65.62 during the morning session, pointing to a modest intraday gain from the opening level.
Recent price action and valuation context
On August 13, 2026, Altria's stock opened at $64.43 before moving higher toward an indicated quote around $65.62 later in the morning, reflecting a daily move a bit under 2 percent from the open and signaling renewed buying interest after a prior 0.9 percent decline in the last session. The current price range leaves the shares trading below key technical levels such as the 50-day and 200-day moving averages, a configuration that often signals consolidation rather than a strong uptrend for income-heavy names.
Recent data from a valuation overview shows Altria changing hands in the mid-50s in EUR terms on its European trading line, with a quoted level of 55.98 EUR at the close on August 12, 2026, down 0.60 percent on the day and roughly 4.47 percent lower over the past five trading days. The same overview indicates a year-to-date performance modestly negative on that line, contrasting with a longer-term pattern where total returns have been driven primarily by dividends rather than sustained capital gains.
Earnings trajectory and latest reported quarter
The freshest consensus and earnings data set points to a steady revenue and profit path across the last several reported quarters up through 2026. For the 2026 first quarter, the financial calendar overview lists net revenue of $4,758 million versus a consensus forecast of $4,578 million, a positive difference of 3.94 percent that indicates slightly stronger than expected top-line performance in the period ending in early 2026. In the same quarter, earnings per share of $4.57 were recorded against an expectation of $4.59, a minor shortfall of 0.35 percent that suggests the company stayed very close to analyst models despite operational pressures.
Moving into the 2026 second quarter, the same calendar shows Altria delivering revenue of $5,356 million compared with a forecast of $5,348 million, a beat of 0.15 percent that underscores stable demand and pricing in the core tobacco portfolio as of the period ending in mid-2026. On the earnings per share side, the latest projection path for 2026 and 2027 points to EPS values in the mid-single-digit range, with expected figures such as $5.54 for 2026 and $5.80 for 2027 marking an implied growth profile built on incremental cost control and disciplined capital allocation.
Looking back at earlier quarters within the freshness window, 2025 data helps frame the evolution. In 2025 first quarter, revenue was reported at $4,519 million against a forecast of $4,615 million, undershooting expectations by 2.09 percent as volumes in traditional combustible products softened. By the 2025 second quarter, revenue had improved to $5,290 million versus a consensus of $5,189 million, a 1.94 percent beat that signaled the company's ability to offset volume declines through pricing adjustments and mix, providing a useful historical comparison against the more recent 2026 numbers.
Consensus view and guidance signals
The same financial calendar and valuation overview suggests that analysts collectively expect Altria's net income and EPS to remain on a relatively stable trajectory over the coming quarters, with net income figures in the range of $8,130 million and $11,264 million in recent fiscal periods and a modest decline to $6,947 million in another period, showcasing how changes in tax, one-time items, or restructuring can affect bottom-line results even when revenue holds steady. The delta between published net income and forecasts, such as a 7.57 percent positive surprise in one period and a 15.4 percent undershoot in another, underscores the importance for investors of monitoring how execution lines up with expectations rather than focusing solely on headline revenue.
Based on the expectations grid extending from 2026 through 2028, projected revenue in future quarters moves in a tight band between roughly $4,742 million and $5,476 million, with forecast EPS figures hovering between $5.54 and $5.96. This range implies low single-digit growth rather than aggressive expansion, reinforcing the narrative of Altria as a cash-generative, income-oriented business rather than a high-growth story. For investors, the number that stands out is the 3.94 percent revenue beat in 2026 first quarter, which, combined with the 0.15 percent beat in 2026 second quarter revenue, signals that the company has recently been delivering slightly stronger top-line results than consensus models had penciled in.
Analyst recommendations and yield appeal
On the analyst front, the latest snapshot of coverage shows Altria receiving an average recommendation that clusters around a hold stance, reflecting a balanced view in which the firm's strong dividend and predictable earnings stream are offset by regulatory risks and structural declines in cigarette volumes. The hold consensus also suggests that most covering analysts consider the shares neither significantly undervalued nor materially overvalued at current levels, but rather fairly priced relative to their outlook for cash flows and payout ratios over the next couple of years.
Dividend yield remains a central part of the story. While specific figures from the latest declaration are not highlighted directly in the fresh data, Altria's history of maintaining a high single-digit yield with regular increases has long been part of its appeal to income-focused shareholders. When compared against broader equity benchmarks and fixed-income alternatives, this yield helps support the valuation multiple even as top-line growth stays subdued, anchoring the case for continued investor interest despite the hold-heavy recommendation mix.
Product spotlight smoke-free portfolio
A key element in Altria's longer-term strategy is the expansion of its smoke-free portfolio, including oral nicotine pouches and heated-tobacco products designed to reduce exposure to combustion-related harms while keeping adult consumers within the company's brand ecosystem. Management has articulated a pathway where gradually shifting revenue from traditional cigarettes toward these smoke-free categories helps stabilize earnings and support the dividend, even as regulatory scrutiny remains intense. For investors, tracking adoption metrics in these newer products over coming quarters will be crucial, as strong uptake could provide an incremental growth driver to complement the stable base business.
Stock level and investor takeaway
As of August 13, 2026, Altria Group stock trading in the mid-$60 range on the NYSE anchors the company firmly among established, income-focused US equities, with recent quarterly revenue beats of 3.94 percent in 2026 first quarter and 0.15 percent in 2026 second quarter underscoring a steady fundamental backdrop for shareholders prioritizing cash returns.
Fact box
Company: Altria Group Inc.
ISIN: US02209S1033
Ticker: MO
Exchange: NYSE
Sector / Industry: Consumer staples / Tobacco
Index membership: S&P 500
